Characteristic | Sex | P | |
Female (n = 60) | Male (n = 44) | ||
Dyslipidemia1 |
|
|
|
Yes | 54 (90) | 37 (84) | .368 |
No | 6 (10) | 7 (16) |
|
Age group |
|
|
|
25 - 35 | 5 (8) | 3 (7) | .732 |
36 - 45 | 11 (18) | 6 (14) |
|
46 - 55 | 12 (20) | 6 (14) |
|
56 - 65 | 21 (35) | 17 (39) |
|
>65 | 11 (18) | 12 (27) |
|
Hypertension2 |
|
|
|
Yes | 40 (67) | 20 (45) | .031 |
No | 20 (33) | 24 (55) |
|
T2D treatment |
|
|
|
OAD + DD + insulin | 6 (10) | 2 (5) | .204 |
OAD + DD | 25 (42) | 28 (64) |
|
Insulin + DD | 5 (8) | 2 (5) |
|
DD | 12 (20) | 8 (18) |
|
Natural plants | 12 (20) | 4 (9) |
|
T2D duration |
|
|
|
1 - 5 | 41 (68) | 31 (70) | .938 |
6 - 10 | 14 (23) | 9 (21) |
|
>10 | 5 (8) | 4 (9) |
|
Hypercreatinemia |
|
|
|
Yes | 7 (12) | 9 (20) | .220 |
No | 53 (88) | 35 (80) |
|
HbA1c, %3 |
|
|
|
< 7 | 14 (23) | 10 (23) | .464 |
7 - 10 | 22 (37) | 21 (48) |
|
>10 | 24 (40) | 13 (29) |
|
Physical activity |
|
|
|
Light | 8 (13) | 9 (20) | .004 |
Moderate | 3 (5) | 11 (25) |
|
Active | 49 (82) | 24 (55) |
|
Atherogenicity index |
|
|
|
Normal | 49 (82) | 38 (86) | .522 |
Elevated | 11 (18) | 6 (14) |
|